Synthesis of new heterocondensed pteridines

Reaction of 2-aminopyrazine 1 with isothiocyanate, isocyanate or dithioketal reagent furnished pteridines 3,4 in good yield. Thioxo compound 3a was chlorinated, methylated and subsequently displaced by amines. A simple one-step synthesis of heterocondensed pteridines 8–13 by reaction of 2-aminopyrazine with various imino thioacetals was described 8–13 .     

Aza-2-diènes-1,3 3. Nouvelles voies d'accès à des amino-2-pyrazines substituées

2-Aza-1,3-dienes. A New Approach to Substituted 2-Aminopyrazines Treatment of enamines by tosylated isonitrosomalono derivatives gives access to 5-dialkylamino-1, 1-dicyano 2-aza-1,3-dienes (or 1-methoxycarbonyl analogous) which are precursors of various regiospecific 5,6-substituted 2-amino-3-cyano (or methoxycarbonyl) pyrazines. Some examples of utilisation of these intermediates for synthesis of lumazines, pteridines, and other bicyclic skeletons are described.     

Pterin chemistry and its relationship to the molybdenum cofactor

The molybdenum cofactor is composed of a molybdenum coordinated by one or two rather complicated ligands known as either molybdopterin or pyranopterin. Pterin is one of a large family of bicyclic N-heterocycles called pteridines. Such molecules are widely found in Nature, having various forms to perform a variety of biological functions. This article describes the basic nomenclature of pterin, their biological roles, structure, chemical synthesis and redox reactivity. In addition, the biosynthesis of pterins and current models of the molybdenum cofactor are discussed.     

A New Synthesis of Pteridines

A new synthesis of pteridines possessing a (substituted) (Z)‐3‐hydroxyprop‐1‐enyl group at C(6) is based on the acylation of 4‐amino‐5‐nitrosopyrimidines with dienoic acid chlorides, followed by a high‐yielding intramolecular hetero‐Diels–Alder cycloaddition and cleavage of the N? O bond leading to 4 . Thermolysis of the resulting pteridines 4 possessing a benzyloxy group at C(4) led to the products 5 , resulting from isomerisation of the 3‐hydroxyprop‐1‐enyl to an 3‐oxopropyl side chain, while the analogous pteridine 8 possessing an NH₂ group at C(4) remained unaffected.     

A prototype solid phase synthesis of pteridines and related heterocyclic compounds

The development of a versatile solid phase synthesis of bicyclic polyaza heterocycles including pteridines, purines, and deazapurines is described. The strategy comprises the linking of a pre-formed pyrimidine through a thioether at the 2 or 4 position to a polystyrene resin, the cyclisation of the second ring, and the direct or oxidative cleavage of the product from the resin by nucleophilic substitution. This provides not only for substituent variation in the second ring, but also for variation at the site of cleavage. Limitations in the scope of the methodology are set by the intrinsic reactivity of pyrimidinyl 2- or 4-thioethers which, whilst undergoing ready nitration at C5, are surprisingly difficult to alkylate and acylate.     

The association and activities of pteridines in photosynthetic systems

Abstract— Unconjugated pteridines are associated with the photosynthetic systems of several organisms. Inhibition of the development of the photosynthetic system of Rhodospirillum rubrum with the pteridine inhibitor 4-phenoxy-2,6-diamino pyridine (PDAP) is reversed by biopterin, a natural pteridine. Evidence is presented which indicates an electron transport function for pteridines. Specific interaction of reduced pteridines with isolated pigment protein complexes, leading to red-shifted absorption bands, has suggested a mechanism for photochemical energy trapping.     

5,6-Diaminocytidine, a versatile synthon for pyrimidine-based bicyclic nucleosides

This communication describes a convenient, facile, and high-yield synthesis of 3-(beta-D-ribofuranosyl)isoguanine and its 8-methyl derivative, as well as nucleoside analogues of pteridines, from a common precursor, 5,6-diaminocytidine. 5,6-Diamino-2',3', 5'-tri-O-benzoylcytidine was synthesized from 4, 6-diamino-2-oxopyrimidine in three steps.     

Kinetic study on the anelation of heterocycles. 3. Pyrazino[2,3-d]pyrimidine derivatives synthesized by the hinsberg reaction

A kinetic study on the obtainment of pyrazinopyrimidine derivatives (pteridines) was performed. The regioselective synthesis of compounds 6-methylpyrazino[2,3-d]pyrimidin-7(8H)-one (5a) and 7-methylpyraz-ino[2,3-d]pyrimidin-6(5H)-one (5b) , in good yields, was expected by the Hinsberg reaction because the synthesis of both isomers analytically pure was never reported to date. This Hinsberg reaction gave good results to obtain compound 5a , regioselectively and in good yields, either in pH 5 aqueous buffer solution or in methylene chloride, among several organic solvents. However, structural and solvation factors prevented the synthesis of the isomer 5b , which was regioselectively formed in very acid solutions (Ho ? ?0.89), but in very poor yield.     

Syntheses of highly functionalised 6-substituted pteridines

Methods for the synthesis of polyfunctional 6-substituted pteridines from the corresponding 6-aldehydes are described. Alkene, ester, ketone, amide, cyano, oxime, bromo, methoxy and dihydroxy functional groups have all been introduced principally through improved methodologies for Wittig reactions using 2-thioalkyl-6-formylpteridines as substrates. Further modification of the alkenes derived from the Wittig reactions was difficult but selective conversion to the vic-diol was possible using ligand assisted catalysis with osmium tetraoxide. These methods are a component of an extensive methodology for the preparation of compounds that might serve as modulators of tetrahydrobiopterin activity or as inhibitors of dihydroneopterin aldolase.     

Biochemistry of the pteridines

Biochemical information about the ubiquitous pteridines has become generally available only within the last fifteen years. This delay can be traced to the chemical lability of these compounds and their small concentrations in organisms. New methods of isolation and isotopic techniques have provided data on the biosynthesis, anabolism, and catabolism of this class of compounds. Hydrogenated pteridines are recognized today as cofactors for various mixed function oxygenases and are involved in cellular electron transport. Further unknown catalytic functions for pteridines in cellular metabolism are indicated by their physiological activity, negative redox potentials, and histoautoradiographic data.     

The synthesis of 7-deazaguanines as potential inhibitors of guanosine triphosphate cyclohydrolase I

Variously substituted 7-deazaguanines are of interest as inhibitors of GTP cyclohydrolase I, the first enzyme in the biosynthetic pathway leading to dihydrofolate and tetrahydrobiopterin. Methods are described for the synthesis of 7-deazaguanines substituted at positions 2, 6 and 9 (purine numbering) such that a wide diversity of compounds can be prepared. These methods supplement our previous work that established routes for the synthesis of 7- and 8-substituted 7-deazaguanines. Emphasis is placed on the properties of 2-thioalkyl pyrimidines as intermediates because they provide the basis for a traceless solid-state synthesis of purines, pteridines, and their analogues. Compounds prepared have been assessed in a primary screen for their ability to inhibit GTPCH I and 8-methyldeazaguanine has been shown to be significantly more potent than any inhibitor yet described. Several compounds appeared to undergo transformation by GTPCH I; with the aid of a model reaction, their behaviour can be interpreted in the context of the mechanism of the hydrolytic phase of GTPCH I.     

Synthesis and biological study of 6‐polyhydroxyalkylpteridines

6‐Polyhydroxyalkylpteridines are synthesised by oxidation of the corresponding pyrano[3,2‐g]pteridines, the latter ones having been obtained by condensation between 5,6‐diaminopyrimidines 1a,b and phenylhydra‐zones 2a‐e . The relative configuration at the chiral centers of the pyrano[3,2‐g]pteridines has been determined by nmr study and X‐ray analysis. The anti‐AIDS activity of several of these compounds has been tested.     

新型1, 6-二取代-5,6-二氢吡咯并[1,2-f]蝶啶衍生物的合成

以Pictet-Spengler型反应为基础, 设计了一条简便的合成1,6-二取代-5,6-二氢吡咯并[1,2-f]蝶啶衍生物的方法. 以4,6-二氯-5-氨基嘧啶为起始原料, 经Clauson-Kaas反应、胺亲核取代两步反应合成了4-氨基-6-氯-5-(1H-吡咯-1-基)-嘧啶, 然后与醛或脂肪酮在对甲苯磺酸催化下, 发生亲电关环得到1-氯-5,6-二氢-6-取代吡咯并[1,2-f]蝶啶, 其1位氯原子具有较高的反应活性, 易于被胺类亲核试剂取代.     

Synthesis of some N-methylated pteridines related to 7,8-dihydroxanthopterin

Seven methylated pteridines have been synthesized by condensation of a 4-chloro-5-nitropyrimidine with a β-ketoamine (or a blocked derivative), reduction of the nitro group, and subsequent ring closure. This scheme provides a new route to dihydroxanthopterin. Several cases are reported, however, in the uracil series where ring closure could not be effected.     

Pteridine. Teil XCIV. Synthese und Eigenschaften von 5,6-Dihydro-6-(1,2,3-trihydroxypropyl)pteridinen: Kovalente intramolekulare Addukte

Pteridines: Synthesis and Characteristics of 5,6-Dihydro-6-(1,2,3-trihydroxypropyl)pteridines: Covalent Intramolecular Adducts Various 5,6-diaminopyrimidines ( 1, 15, 24, 33 ) were condensed with the phenylhydrazones of L -( 2 ) and D -arabinose ( 3 ) in acidic medium under N₂ to give formal 5,6-dihydro-6-(1,2,3-trihydroxypropyl)pteridines (see, e.g., 4 and 5 ), the latter turned out to exist preferentially as intramolecular adducts, the hexahydropyrano-[3,2-g]pteridines 6, 7, 16, 17, 25, 26 , and 34 , formed subsequently by addition of the terminal OH group of the side-chain to the C(7)?N(8) bond of the pteridine moiety. Spectroscopically, the isomeric hexahydrofuro-[3,2-g]pteridines 10,11,18,19 , and 35 were also detected as minor components in the equilibrium mixtures. In the 4-amino-2-(methylthio)pteridine series, crystallization of 6 and 7 led to the stereochemically pure (3S,4R,4aR, 10aS)-6-amino-3,4,4a,5,10,10a-hexahydro-8-(methylthio)-2H-pyrano[3,2-g]pteridine-3,4-diol ( 8 ) and its corresponding enantiomer 9 , respectively Structure 8 was proven by X-ray analysis. Acylation of the hexahydropyrano[3,2-g]pteridines yielded the more stable tri-, tetra-, and pentaacetyl derivatives 12–14, 20–23, 27–32 , and 37–39 which were characterized and of which the absolute and relative configurations were determined (¹H- and ¹³C–NMR and UV spectra, chiroptical measurements, elemental analyses).     

Electronic structure and properties of pteridines and N-alkylpteridinium salts

The electronic structure of pteridines and N-methylpteridinium cations was calculated in terms of the CNDO/2 approximation. The obtained data on the electron density distribution in the molecules of pteridines and also the energy characteristics of the pteridinium cations make it possible to predict the outcome of quaternization. The results from the calculations are compared with the experimental data. It is shown that the direction of nucleophilic attack in N-alkylpteridinium cations correlates with the total charge of the fragment of the covalently bonded atoms.Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 8, pp. 1118–1125, August, 1989.     

Computation of affinity and selectivity: Binding of 2,4-diaminopteridine and 2,4-diaminoquinazoline inhibitors to dihydrofolate reductases

Binding energy calculations for complexes of mutant and wild-type human dihydrofolate reductases with 2,4-diaminopteridine and 2,4-diaminoquinazoline inhibitors are reported. Quantitative insight into binding energetics of these molecules is obtained from calculations based on force field energy evaluation and thermal sampling by molecular dynamics simulations. The calculated affinity of methotrexate for wild-type and mutant enzymes is reasonably well reproduced. Truncation of the methotrexate glutamate tail results in a loss of affinity by several orders of magnitude. No major difference in binding strength is predicted between the pteridines and the quinazolines, while the N-methyl group present in methotrexate appears to confer significantly stronger binding. The recent improvement, which is used here, of our linear interaction energy method for binding affinity prediction, as well as problems with treating charged and flexible ligands are discussed. This approach should be suitable in a drug discovery context for prediction of binding energies of new inhibitors prior to their synthesis, when some information about the binding mode is available.     

Protonenresonanzspektren von Pteridinen (VI). Mono- und Dikationen von 2-Amino-4-oxo-3, 4-dihydropteridinen

Proton NMR. spectra of 18 pteridines have been measured in strongly acidic solutions. In trifluoroacidic acid mono-cations are formed whereas in fluorosulfonic acid double protonation occurs. For the first time di-cations of pteridines are described, and the structures of these species are determined by NMR. and UV. data. The chemical shifts of the NH₂ protons in the mono-cations and of the methyl protons in the mono- and di-cations follow linear correlations with the basic pK_a values. From NMR. variable temperature measurements the energy barrier to internal rotation in the amidinium system has been ddtermined for both cations. The results are discussed with particular regard to the structure of the mono-and di-cations.     

Target analogue imprinted polymers with affinity for folic acid and related compounds.

Two approaches to synthesize molecularly imprinted polymers with affinity for folic acid and other substituted pteridines have been compared. In the first approach, the folic acid analogue methotrexate was used as template and functional monomers capable of generating selective binding sites were searched in a miniaturized screening system based on binding assessment in the batch mode. Highest selectivity was seen using 2-vinylpyridine as functional monomer, which was confirmed in the chromatographic mode for a batch synthesized on a gram scale. However, the retentivity and selectivity of this phase were insufficient for anticipated applications. In a second approach, using methacrylic acid as the functional monomer, organic soluble inhibitors for the enzyme dihydrofolate reductase were used to develop sites complementary toward the pteridine substructure. This resulted in materials showing enhanced selectivity for substituted pteridines when evaluated by HPLC. Thus, methotrexate and leucovorine were selectively retained in mobile phases of either low or high aqueous content, thus showing the typical bimodal retention behavior of previously reported MIPs. In organic mobile-phase systems, the inhibitor used as template had an influence on the retentivity and selectivity of the MIP. The polymer imprinted with trimethoprim retained all folic acid analogues strongly and showed the highest selectivity among the MIPs in an organic mobile-phase system. This was supported by Scatchard analysis resulting in biphasic plots and a quantitative yield of high-energy binding sites. All templates were shown to associate strongly with MAA in CDCl(3), the strength of association correlating roughly with the template basicity and the selectivity observed in chromatography. Nonparallel complexation-induced shifts indicated formation of 1:2 template monomer complexes at concentrations corresponding to those of the prepolymerization solutions.